全球医疗射出成型市场－按材料、系统、产品、地区和预测的市场规模

医疗射出成型市场规模及预测

2024 年医疗射出成型市场规模价值 230.4 亿美元，预计到 2032 年将达到 341.2 亿美元，2026 年至 2032 年的复合年增长率为 5.55%。

• 医用射出成型是一种专业的製造方法，能够生产出高精度、一致性高、品质优的医用塑胶零件。此方法将熔融的塑胶零件注入模腔，冷却并固化成所需形状。医用射出成型成型对于製造各种医疗设备中使用的先进复杂部件至关重要，包括注射器、植入、手术器材和诊断工具。
• 该系统广泛应用于各种医疗设备和零件的製造，确保高精度、高可靠性和一致性——这些都是医疗保健产业的关键要素。最常见的应用之一是生产手术器械，例如钳子、牵开器和夹钳。这些器材设计精良，必须符合高品质标准，才能在医疗过程中顺利安全地发挥作用。
• 对极其精密可靠的医疗部件的需求正在推动医疗射出成型的未来发展。随着医疗设备和器械的日益先进，製造流程的精确度至关重要。未来的射出成型技术将利用微成型和奈米技术等尖端技术，生产公差极小、结构复杂的零件。

全球医疗射出成型市场动态

影响全球医疗射出成型市场的关键市场动态是：

关键市场驱动因素

• 医疗技术和材料的进步：医疗射出成型市场的主要驱动力之一是医疗技术和材料的进步。医疗产业需要能够利用射出成型技术高效生产的高精度、高可靠性零件。
• 射出成型技术进步：射出成型技术的发展是医疗射出成型产业的另一个主要驱动力。微射出成型、多材料成型以及自动化技术进步等创新大大改进了射出成型操作。微射出成型能够生产极微小且精密的零件，而这些零件在微创手术和植入式医疗设备中的需求日益增长。
• 严格的监管标准和品管：医疗设备对安全性、品质和性能有严格的要求，医疗产业也受到广泛的监管。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构对医疗设备製造商制定了严格的规定。医疗射出成型作业必须遵守这些准则，以确保生产的零件不含杂质和缺陷。

主要挑战

• 严格的法规合规性：医疗射出成型最具挑战性的方面之一是满足严格的监管标准。医疗产业受到严格监管，美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等机构对医疗设备和零件的製造实施了严格的标准。
• 材料选择与相容性：选择合适的医用射出成型材料至关重要，但由于医疗应用的独特需求，选择合适的材料也极具挑战性。所用材料必须具有生物相容性、耐久性，并且能够耐受高压高压釜、伽马射线辐照和环氧乙烷处理等灭菌技术。此外，材料还必须具备理想的机械性能，包括柔韧性、强度和耐化学性。
• 精度与品管：医疗射出成型需要高精度和严格的品管，才能生产出符合严格标准的零件。医疗设备具有复杂的几何形状和严格的公差，必须一致地满足这些要求，才能确保其功能性和安全性。维持这种完美品质需要创新的成型技术、先进的设备以及严格的检验和测试通讯协定。

主要趋势：

• 采用先进材料：医疗射出成型成型的一个关键发展是先进材料的使用日益增多。聚丙烯和聚乙烯正在被聚醚醚酮 (PEEK)、聚碳酸酯 (PC) 和热可塑性橡胶(TPE) 等高性能聚合物所补充，在某些情况下甚至被取代。
• 精密和微成型能力：精密和微成型能力在医疗射出成型产业中日益重要。医疗器材越来越小，需要复杂而精密的零件。微成型能够生产公差高、形状复杂的微型零件，满足微创手术器械、药物输送系统和微流体设备等应用的需求。
• 自动化和智慧生产：自动化和智慧生产正在彻底改变医疗射出成型产业。机器人、人工智慧 (AI) 和物联网 (IoT) 在製造过程中的应用提高了效率、品质和可追溯性。自动化系统可以更快、更准确地执行重复性任务，从而降低人为错误的风险并提高生产力。

目录

第一章：全球医疗射出成型市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球医疗射出成型市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球医疗射出成型市场（按材料）

• 概述
• 塑胶
• 金属
• 其他的

6. 全球医疗射出成型市场（按系统）

• 概述
• 热流道
• 冷流道

第七章全球医疗射出成型市场（按产品）

• 概述
• 医疗设备组件
• 耗材
• 病人辅助器具
• 整形外科设备
• 牙科产品
• 其他的

8. 全球医疗射出成型市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第九章全球医疗射出成型市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第十章 公司简介

• C&J INDUSTRIES
• All-Plastics
• Biomerics
• HTI Plastics
• The Rodon Group
• EVCO Plastics
• Majors Plastics, Inc
• Proto Labs, Inc
• Tessy Plastics
• Currier Plastics, Inc.

第十一章 附录

• 相关调查

Medical Injection Molding Market Size And Forecast

Medical Injection Molding Market size was valued at USD 23.04 Billion in 2024 and is projected to reach USD 34.12 Billion by 2032, growing at a CAGR of 5.55% during the forecast period 2026-2032.

• Medical injection molding is a specialized manufacturing method that produces medical-grade plastic components with exceptional precision, consistency, and quality. This method includes injecting molten plastic components into a mold cavity, where they cool and solidify to the desired shape. The medical injection molding method is very important for making sophisticated and intricate components used in a variety of medical devices, including syringes, implants, surgical instruments, and diagnostic tools.
• This system is widely utilized in the manufacturing of a variety of medical devices and components ensuring high precision, dependability, and consistency all of which are vital in the healthcare industry. One of the most common applications is the manufacture of surgical equipment like forceps, retractors, and clamps. These instruments must be intricately designed and meet high-quality criteria to perform successfully and safely during medical procedures.
• The requirement for extremely precise and reliable medical components is propelling the future of medical injection molding forward. As medical devices and equipment become more advanced, precision in manufacturing processes is critical. Future injection molding technologies will use cutting-edge advancements like micro molding and nanotechnology to create exceedingly small and complicated components with tight tolerances.

Global Medical Injection Molding Market Dynamics

The key market dynamics that are shaping the global medical injection molding market include:

Key Market Drivers:

• Advances in Medical Technology and Materials: One of the key drivers of the medical injection molding market is the ongoing progress of medical technology and materials. The medical business requires extremely precise and reliable components that may be efficiently manufactured utilizing injection molding techniques.
• Technological Advancements in Injection Molding: Technological developments in injection molding are another significant driver of the medical injection molding industry. Innovations such as micro-injection molding, multi-material molding, and increased automation have considerably improved injection molding operations. Micro-injection molding enables the manufacture of extremely small and delicate components which are increasingly required for minimally invasive surgical and implanted medical devices.
• Stringent Regulatory Standards and Quality Control: The medical business is extensively regulated, with strict safety, quality, and performance requirements for medical equipment. Regulatory authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require medical device makers to follow strict rules. Medical injection molding operations must adhere to these guidelines guaranteeing that the components produced are free of impurities and flaws.

Key Challenges:

• Severe Regulatory Compliance: One of the most difficult aspects of medical injection molding is meeting severe regulatory criteria. The medical business is heavily regulated with authorities like the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe imposing stringent standards on the manufacture of medical devices and components.
• Material Selection and Compatibility: Choosing the right materials for medical injection molding is vital but difficult due to the specific needs of medical applications. The materials utilized must be biocompatible, long-lasting, and resistant to sterilization techniques like autoclaving, gamma irradiation, or ethylene oxide treatment. Additionally, they must have the desired mechanical qualities, such as flexibility, strength, and chemical resistance.
• Precision and Quality Control: To make components that satisfy rigorous standards, medical injection molding demands a high level of precision and stringent quality control. Medical equipment can have complex geometries and strict tolerances which must be consistently satisfied to ensure appropriate function and safety. Maintaining this degree of perfection requires innovative molding techniques, cutting-edge machinery, and stringent inspection and testing protocols.

Key Trends:

• Adoption of Sophisticated Materials: One important development in medical injection molding is the increased usage of sophisticated materials. Polypropylene and polyethylene are being supplemented and in some cases replaced, by high-performance polymers such as polyetheretherketone (PEEK), polycarbonate (PC), and thermoplastic elastomers (TPE).
• Precision and Micro-Molding Capabilities: Precision and micro-shaping capabilities are becoming increasingly important in the medical injection molding business. Medical gadgets are becoming progressively shrunk necessitating intricate and accurate components. Micro-molding produces extremely small parts with high tolerances and complicated geometries which are required for applications such as minimally invasive surgical instruments, drug delivery systems, and microfluidic devices.
• Automation and Smart Manufacturing: Automation and smart production are revolutionizing the medical injection molding business. The use of robotics, artificial intelligence (AI), and the Internet of Things (IoT) in manufacturing processes improves efficiency, quality, and traceability. Automated systems can do repetitive activities more quickly and accurately lowering the risk of human error and increasing production productivity.

Global Medical Injection Molding Market Regional Analysis

Here is a more detailed regional analysis of the global medical injection molding market:

Asia Pacific:

• The Asia-Pacific region is emerging as a prominent force in the medical injection molding market owing to a mix of variables such as a large and aging population, rising chronic disease rates, and rapid economic expansion. The United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) projects that the region's population will reach 4.6 billion by 2050 with the senior population (aged 65 and up) likely to double from 395 million in 2020 to 783 million by 2050. This demographic transition is especially significant in countries like Japan where the National Institute of Population and Social Security Research forecasts that 28.4% of the population will be 65 or older in 2020 with that percentage predicted to climb to 35.3% by 2040.
• For example, the International Diabetes Federation (IDF) predicted that in 2019, 163 million persons in the Western Pacific region had diabetes with the figure expected to climb to 212 million in 2045. These demographic and health trends are driving the demand for injection-molded medical devices and components such as insulin delivery systems, diagnostic equipment, and other medical implants. Furthermore, the rapid expansion of the healthcare sector in Asia-Pacific countries is driving the medical injection molding market forward. China for example has made significant investments in healthcare infrastructure and technology. According to the National Health Commission of China, healthcare spending in the country will total 6.52 trillion yuan (about USD 1 trillion) in 2020 up 10.2% over the previous year.

North America:

• The medical injection molding market in North America is rapidly expanding owing to a combination of reasons such as an aging population, an increase in the frequency of chronic diseases, and technological advances in healthcare. According to the United States Census Bureau, the number of Americans aged 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060 with their share of the total population rising from 16% to 23%. This demographic transition has a substantial impact on the demand for medical devices and injection-molded components. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 persons in the United States have at least one chronic disease with 4 in 10 having two or more.
• Chronic diseases such as heart disease, cancer, and diabetes are America's major causes of mortality and disability, necessitating the development of innovative medical technologies and therapies. The medical injection molding market in North America is being fueled by increased investments in healthcare infrastructure and research and development. The National Institutes of Health (NIH) budget for fiscal year 2021 was USD 42.9 Billion representing a significant increase over previous years and demonstrating a strong commitment to medical research and innovation.

Global Medical Injection Molding Market: Segmentation Analysis

The Global Medical Injection Molding Market is segmented based on Material, Systems, Product, and Geography.

Medical Injection Molding Market, By Material

• Plastics
• Metals
• Others

Based on the Material, the Global Medical Injection Molding Market is bifurcated into Plastics, Metals, and Others. Plastics dominate the global medical injection molding market due to their versatility, cost-effectiveness, and excellent properties for medical applications. Plastics such as polypropylene, polyethylene, and polyetheretherketone (PEEK) offer high biocompatibility, chemical resistance, and mechanical strength making them ideal for producing a wide range of medical components like syringes, implants, and diagnostic devices. Additionally, plastics can be easily sterilized and molded into complex shapes with precise tolerances which is essential for the medical industry.

Medical Injection Molding Market, By Systems

• Hot Runner
• Cold Runner

Based on Systems, the Global Medical Injection Molding Market is bifurcated into Hot Runner and Cold Runner. The hot runner system is dominant in the global medical injection molding market. This dominance is due to its numerous advantages over the cold runner system, particularly in producing high-precision medical components. Hot runner systems allow for better control of the molding process resulting in higher-quality parts with fewer defects. They eliminate the need for runners reducing material waste and lowering production costs. Additionally, hot runner systems enable faster cycle times and increased production efficiency essential for high-volume manufacturing.

Medical Injection Molding Market, By Product

• Medical Equipment Components
• Consumables
• Patient Aids
• Orthopedics Instruments
• Dental Products
• Others

Based on the Product, the Global Medical Injection Molding Market is bifurcated into Medical Equipment Components, Consumables, Patient Aids, Orthopedics Instruments, Dental Products, and Others. The dominant segment in the medical injection molding market is medical equipment components. This dominance is driven by the high demand for precision-engineered parts used in a wide range of medical devices such as diagnostic equipment, surgical instruments, and drug delivery systems. The need for components that meet strict regulatory standards for safety and biocompatibility is critical in the healthcare sector. Advances in injection molding technology allow for the production of complex, high-quality parts with tight tolerances which are essential for the reliable performance of medical equipment.

Medical Injection Molding Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Medical Injection Molding Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global medical injection molding market. This dominance is attributed to several factors including the region's robust healthcare infrastructure, high demand for advanced medical devices, and stringent regulatory standards favoring quality and innovation. North American countries particularly the United States are home to a significant number of medical device manufacturers and research institutions driving technological advancements in the field of medical injection molding. Moreover, the presence of a large patient population coupled with substantial healthcare expenditures fuels continuous demand for high-quality medical devices and components. The region's strong focus on healthcare innovation coupled with strategic investments in R&D and manufacturing capabilities, further solidifies North America's position as a leader in the global medical injection molding market.

Key Players

The "Global Medical Injection Molding Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are C&J INDUSTRIES, All-Plastics, Biomerics, HTI Plastics, The Rodon Group, EVCO Plastics, Majors Plastics, Inc., Proto Labs, Inc., Tessy Plastics, Currier Plastics, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Medical Injection Molding Market Key Developments

• In November 2023, ARBURG, a major participant in the medical injection molding sector, expanded its global reach by establishing a new subsidiary in Ho Chi Minh City, Vietnam. This strategic decision intends to make ARBURG's goods and services more accessible to clients in Vietnam, thereby enhancing the company's position in the region.
• In September 2023, Milacron, a major leader in the worldwide plastics technology and processing business, delivered the injection molding machine to its long-term customer, Holiday City, Ohio-based 20/20 Custom Molded Plastics, LLC.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL INJECTION MOLDING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MEDICAL INJECTION MOLDING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY MATERIAL

• 5.1 Overview
• 5.2 Plastics
• 5.3 Metals
• 5.4 Others

6 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY SYSTEMS

• 6.1 Overview
• 6.2 Hot Runner
• 6.3 Cold Runner

7 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY PRODUCT

• 7.1 Overview
• 7.2 Medical Equipment Components
• 7.3 Consumables
• 7.4 Patient Aids
• 7.5 Orthopedics Instruments
• 7.6 Dental Products
• 7.7 Others

8 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL MEDICAL INJECTION MOLDING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 C&J INDUSTRIES
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 All-Plastics
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Biomerics
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 HTI Plastics
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 The Rodon Group
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 EVCO Plastics
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Majors Plastics, Inc
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Proto Labs, Inc
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Tessy Plastics
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Currier Plastics, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research